FDA Inspection 1192829 — One Blood Inc

One Blood Inc — FEI 3004054586

The FDA completed an inspection of One Blood Inc on November 30, 2022 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 30, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)